Biolight is a publicly-traded company focused on the development and commercialization of companies and products which address unmet needs and various Ophthalmic conditions. Its current products and portfolio companies address various diseases including mainly dry eye syndrome and glaucoma. Its portfolio companies and products are providing better devices, diagnostics, and drugs. Its delivery and diagnostics platforms reduce patient non-compliance with drug therapy administration, improve efficacy and safety of treatment, and help to personalize the medications.